Data / Drug companies / Pramipexole dihydrochloride
Pramipexole dihydrochloride: 23 companies and 131 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pramipexole dihydrochloride is listed in the FDA National Drug Code Directory by 23 companies, with 131 products in commercial distribution. 131 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release, and the newest product started marketing on March 10, 2022.
The request: Get every company that lists pramipexole dihydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 131
- Generic (ANDA) products
- 131 (100.0%)
- Application numbers
- 13
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list pramipexole dihydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Alembic Pharmaceuticals Limited | 17 | tablet; tablet, extended release | Generic drugs (ANDA) | January 3, 2019 |
| Alembic Pharmaceuticals Inc. | 12 | tablet, extended release; tablet | Generic drugs (ANDA) | January 3, 2019 |
| Macleods Pharmaceuticals Limited | 12 | tablet, extended release; tablet | Generic drugs (ANDA) | August 24, 2020 |
| Ingenus Pharmaceuticals, LLC | 7 | tablet, extended release | Generic drugs (ANDA) | March 10, 2022 |
| Aurobindo Pharma Limited | 6 | tablet | Generic drugs (ANDA) | October 26, 2012 |
| Bryant Ranch Prepack | 6 | tablet | Generic drugs (ANDA) | October 26, 2012 |
| Glenmark Pharmaceuticals Inc., USA | 6 | tablet | Generic drugs (ANDA) | January 31, 2016 |
| Golden State Medical Supply, Inc. | 6 | tablet | Generic drugs (ANDA) | October 28, 2014 |
| NorthStar Rx LLC | 6 | tablet, extended release | Generic drugs (ANDA) | March 6, 2019 |
| Rising Pharma Holdings, Inc. | 6 | tablet | Generic drugs (ANDA) | October 26, 2012 |
| ScieGen Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | October 29, 2014 |
| Strides Pharma Science Limited | 6 | tablet | Generic drugs (ANDA) | February 15, 2021 |
| Torrent Pharmaceuticals Limited | 6 | tablet | Generic drugs (ANDA) | October 8, 2010 |
| Unichem Pharmaceuticals (USA), Inc. | 6 | tablet | Generic drugs (ANDA) | March 1, 2019 |
| Dr. Reddy's Laboratories Limited | 5 | tablet, extended release | Generic drugs (ANDA) | August 14, 2015 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | October 26, 2012 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | August 18, 2020 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | October 26, 2012 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | October 8, 2010 |
| Vitruvias Therapeutics | 2 | tablet, extended release | Generic drugs (ANDA) | August 27, 2021 |
| Xiamen LP Pharmaceutical Co., Ltd. | 2 | tablet, extended release | Generic drugs (ANDA) | June 11, 2021 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | October 8, 2010 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | October 8, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 88 | 67.2% |
| Tablet, extended release | 43 | 32.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 131 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nonergot Dopamine Agonist | 131 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.